[go: up one dir, main page]

MX2009006325A - Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. - Google Patents

Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.

Info

Publication number
MX2009006325A
MX2009006325A MX2009006325A MX2009006325A MX2009006325A MX 2009006325 A MX2009006325 A MX 2009006325A MX 2009006325 A MX2009006325 A MX 2009006325A MX 2009006325 A MX2009006325 A MX 2009006325A MX 2009006325 A MX2009006325 A MX 2009006325A
Authority
MX
Mexico
Prior art keywords
quinoxalinone
quinolinone
derivatives
antibacterial agents
compounds
Prior art date
Application number
MX2009006325A
Other languages
English (en)
Inventor
Janelle Comita-Prevoir
Mark Cronin
Bolin Geng
Andrew Aydon Godfrey
Folkert Reck
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39046831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009006325(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2009006325A publication Critical patent/MX2009006325A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula (1), y sales farmacéuticamente aceptables del mismo, a su uso en el tratamiento de infecciones bacteriales, y a sus métodos de preparación.
MX2009006325A 2006-12-15 2007-12-13 Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. MX2009006325A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87018106P 2006-12-15 2006-12-15
US96916307P 2007-08-30 2007-08-30
PCT/GB2007/004766 WO2008071961A1 (en) 2006-12-15 2007-12-13 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
MX2009006325A true MX2009006325A (es) 2009-07-24

Family

ID=39046831

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006325A MX2009006325A (es) 2006-12-15 2007-12-13 Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.

Country Status (17)

Country Link
EP (1) EP2121702A1 (es)
JP (1) JP2010513255A (es)
KR (1) KR20090090385A (es)
AR (1) AR064369A1 (es)
AU (1) AU2007331247B2 (es)
BR (1) BRPI0720236A2 (es)
CA (1) CA2671485A1 (es)
CL (1) CL2007003641A1 (es)
CO (1) CO6190619A2 (es)
EC (1) ECSP099506A (es)
MX (1) MX2009006325A (es)
NO (1) NO20092655L (es)
PE (1) PE20081511A1 (es)
RU (1) RU2009126731A (es)
TW (1) TW200831517A (es)
UY (1) UY30788A1 (es)
WO (1) WO2008071961A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
US8507478B2 (en) 2008-10-10 2013-08-13 Actelion Pharmaceuticals Ltd. Oxazolidinyl antibiotics
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
KR20140033309A (ko) * 2010-10-04 2014-03-18 브리티쉬 콜롬비아 캔써 에이전시 브랜치 위장 암을 진단하기 위해 위장의 샘플에서의 푸소박테리움의 검출
EP4635568A3 (en) 2017-08-21 2025-12-03 ACADIA Pharmaceuticals Inc. Compounds, salts thereof and methods for treatment of diseases
EP3672960A2 (en) * 2017-08-21 2020-07-01 Acadia Pharmaceuticals Inc. Compounds, salts thereof and their use for the treatment of diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
JP5314244B2 (ja) * 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) * 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
KR101409261B1 (ko) * 2006-05-26 2014-06-18 다이쇼 세이야꾸 가부시끼가이샤 신규의 복소환 화합물 또는 그 염 및 그 중간체
EP2029612A1 (en) * 2006-06-09 2009-03-04 Glaxo Group Limited Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
JP5315239B2 (ja) * 2006-07-20 2013-10-16 グラクソ グループ リミテッド Ｎ−エチルキノロンおよびｎ−エチルアザキノロンの誘導体およびアナログ
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones

Also Published As

Publication number Publication date
KR20090090385A (ko) 2009-08-25
ECSP099506A (es) 2009-08-28
AU2007331247A1 (en) 2008-06-19
CL2007003641A1 (es) 2008-09-22
RU2009126731A (ru) 2011-01-20
AU2007331247B2 (en) 2011-10-20
AR064369A1 (es) 2009-04-01
CA2671485A1 (en) 2008-06-19
JP2010513255A (ja) 2010-04-30
CO6190619A2 (es) 2010-08-19
NO20092655L (no) 2009-09-02
TW200831517A (en) 2008-08-01
UY30788A1 (es) 2008-07-31
EP2121702A1 (en) 2009-11-25
BRPI0720236A2 (pt) 2013-12-24
PE20081511A1 (es) 2008-12-12
WO2008071961A8 (en) 2009-10-22
WO2008071961A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
UA96964C2 (ru) Соединения полициклической мочевины с антибактериальными свойствами
EA201100613A1 (ru) Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
MX340533B (es) Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
MX348974B (es) Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
MX2007010072A (es) Derivados de piperidina antibacterianos.
NZ593111A (en) Antibacterial compounds
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
UA92637C2 (en) Pyridine[3,4-b]pyrazinones
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
MY198204A (en) Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
WO2010084115A3 (en) Antiviral agents
MX2010008921A (es) Derivados de oxazolidinona.
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
NZ616764A (en) Mannose derivatives as antagonists of bacterial adhesion
MX2009012390A (es) Uso de compuestos de 4-(pirrolidin-1-il)quinolina para exterminar microorganismos clinicamente latentes.
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
HRP20090074T3 (en) 3,11b cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
WO2013106761A3 (en) Antimicrobial agents
NZ596628A (en) Ketolide compounds having antimicrobial activity
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal